BAW 2881

BAW 2881

CAT N°: 18910
Price:

From 66.00 56.10

BAW 2881 is a vascular endothelial growth factor receptor (VEGFR) inhibitor (IC50s = 0.82, 0.037, and 0.42 µM for hVEGFR1, 2, and 3, respectively).{31717} It inhibits Tie2 and RET with IC50 values of 0.65 and 0.41 µM, respectively, but demonstrates IC50 values great than 10 µM toward a large panel of additional kinases.{31717} BAW 2881 was shown to block VEGF-A-induced proliferation, migration, and tube formation of human umbilical vein endothelial cells and lymphatic endothelial cells in vitro.{31717} In a mouse model of psoriasis, both oral and topical administration of BAW 2881 reduced psoriasis-like inflammation in ear skin.{31717} Topical application of BAW 2881 also reduced VEGF-A-induced vascular permeability and inhibited contact hypersensitivity reactions and UV-B-induced erythema in the skin of domestic pigs.{31717}

We also advise you